In Silico Evaluation of Expressed TB Fusion CFP10-ESAT-6 Reveals Promising Diagnostic and Therapeutic Potential
Main Article Content
Abstract
Tuberculosis (TB) an opportunistic disease still remains a major cause of death globally after COVID-19 pandemic and HIV.Enhanced microbial resistance to therapeutic drugs has paved way to introducing new vaccines for prophylactic control of the disease. Timely diagnosis of TB is also highly needed for effective treatment. Therefore,afastreliablediagnostic methodwith high sensitivity is need of the day. In our study, CFP10 and ESAT-6 antigens were cloned, expressed, and purified individually and as a chimeric construct in Escherichiacoli BL21. Epitopic analysis revealed that the CFP10-ESAT-6 (CEP) chimeric construct may be more sensitive than the individual sensitivities of CFP10 and ESAT-6. Moreover, molecular analysis of secondary structure and 3-D modelling of each construct also validated that CEP may prove a better immunodiagnostic tool in addition to previously reported EC skin test.
Article Details

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Pakistan Journal Emerging Science and Technologies (PJEST) in collaboration with Govt. Islamia Graduate College Civil Lines Lahore, Pakistan is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
M. Reid, S. Silva, and E. P. Goosby, "World TB day: a new opportunity to reimagine workplace health," BMJ Global Health, vol. 6, no. 3, p. e005601, 2021.
F. Zhou, X. Xu, S. Wu, X. Cui, L. Fan, and W. Pan, "Protein array identification of protein markers for serodiagnosis of Mycobacterium tuberculosis infection," Scientific reports, vol. 5, no. 1, p. 15349, 2015.
Z. Yan et al., "Evaluation of panels of Mycobacterium tuberculosis antigens for serodiagnosis of tuberculosis," The International Journal of Tuberculosis and Lung Disease, vol. 22, no. 8, pp. 959-965, 2018.
M. Afzal, S. Khurshid, R. Khalid, R. Z. Paracha, I. H. Khan, and M. W. Akhtar, "Fusion of selected regions of mycobacterial antigens for enhancing sensitivity in serodiagnosis of tuberculosis," Journal of microbiological methods, vol. 115, pp. 104-111, 2015.
M. Akhter, S. Arif, A. Khaliq, Z. un Nisa, I. H. Khan, and M. W. Akhtar, "Designing fusion molecules from antigens of Mycobacterium tuberculosis for detection of multiple antibodies in plasma of TB patients," Tuberculosis, vol. 124, p. 101981, 2020.
S. Sulman et al., "Enhanced serodiagnostic potential of a fusion molecule consisting of Rv1793, Rv2628 and a truncated Rv2608 of Mycobacterium tuberculosis," Plos one, vol. 16, no. 11, p. e0258389, 2021.
S. Arif, M. Akhter, A. Khaliq, Z. un Nisa, I. H. Khan, and M. W. Akhtar, "Serodiagnostic evaluation of fusion proteins from multiple antigens of Mycobacterium tuberculosis for active TB," Tuberculosis, vol. 127, p. 102053, 2021.
S. Khurshid, M. Afzal, R. Khalid, I. H. Khan, and M. W. Akhtar, "Improving sensitivity for serodiagnosis of tuberculosis using TB16. 3-echA1 fusion protein," Tuberculosis, vol. 94, no. 5, pp. 519-524, 2014.
S. Khurshid, R. Khalid, M. Afzal, and M. W. Akhtar, "Truncation of PstS1 antigen of Mycobacterium tuberculosis improves diagnostic efficiency," Tuberculosis, vol. 93, no. 6, pp. 654-659, 2013.
A. M. Abdallah et al., "Type VII secretion—mycobacteria show the way," Nature reviews microbiology, vol. 5, no. 11, pp. 883-891, 2007.
M. Behr et al., "Comparative genomics of BCG vaccines by whole-genome DNA microarray," Science, vol. 284, no. 5419, pp. 1520-1523, 1999.
L. Chen et al., "The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10: ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants," FEMS Immunology & Medical Microbiology, vol. 59, no. 1, pp. 42-52, 2010.
M. E. Sarmiento et al., "Immunoinformatics study on highly expressed Mycobacterium tuberculosis genes during infection," Tuberculosis, vol. 94, no. 5, pp. 475-481, 2014.
G. J. Jones, A. Whelan, D. Clifford, M. Coad, and H. M. Vordermeier, "Improved skin test for differential diagnosis of bovine tuberculosis by the addition of Rv3020c-derived peptides," Clinical and Vaccine Immunology, vol. 19, no. 4, pp. 620-622, 2012.
H. Köhler et al., "Immune reactions in cattle after immunization with a Mycobacterium paratuberculosis vaccine and implications for the diagnosis of M. paratuberculosis and M. bovis infections," Journal of Veterinary Medicine, Series B, vol. 48, no. 3, pp. 185-195, 2001.
S. H. Kaufmann et al., "Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review," The lancet Respiratory medicine, vol. 2, no. 4, pp. 301-320, 2014.
T. Hsu et al., "The primary mechanism of attenuation of bacillus Calmette–Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue," Proceedings of the National Academy of Sciences, vol. 100, no. 21, pp. 12420-12425, 2003.
N. Aguilo, S. Uranga, D. Marinova, M. Monzon, J. Badiola, and C. Martin, "MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice," Tuberculosis, vol. 96, pp. 71-74, 2016.
N. Aguilo et al., "Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis," Nature communications, vol. 8, no. 1, p. 16085, 2017.
R. Vita et al., "The immune epitope database 2.0," Nucleic acids research, vol. 38, no. suppl_1, pp. D854-D862, 2010.
R.-P. T. Larsen and A. Studentlitteratur, "Lund," ed: Sweden, 2003.
R. Khalid, M. Afzal, S. Khurshid, R. Z. Paracha, I. H. Khan, and M. W. Akhtar, "Fusion molecules of heat shock protein HSPX with other antigens of Mycobacterium tuberculosis show high potential in serodiagnosis of tuberculosis," PloS one, vol. 11, no. 9, p. e0163349, 2016.
J. Sambrook, "Plasmid and their usefulness in molecular cloning," Molecular cloning, a laboratory manual, vol. 1, pp. 1.31-1.162, 2001.
M. Källberg et al., "Template-based protein structure modeling using the RaptorX web server," Nature protocols, vol. 7, no. 8, pp. 1511-1522, 2012.
P. C. Hopewell, M. Pai, D. Maher, M. Uplekar, and M. C. Raviglione, "International standards for tuberculosis care," The Lancet infectious diseases, vol. 6, no. 11, pp. 710-725, 2006.
G. Scarabelli, G. Morra, and G. Colombo, "Predicting interaction sites from the energetics of isolated proteins: a new approach to epitope mapping," Biophysical journal, vol. 98, no. 9, pp. 1966-1975, 2010.
S. J. de Vries and A. M. Bonvin, "CPORT: a consensus interface predictor and its performance in prediction-driven docking with HADDOCK," PloS one, vol. 6, no. 3, p. e17695, 2011.